Home › Compare › Klotho vs FOXO4-DRI
Klotho vs FOXO4-DRI
Klotho and FOXO4-DRI are both longevity peptides, which is why they get recommended interchangeably — but they are different compounds with different origins. The table below sets out the differences. We give no dosing guidance.
Side by side, in plain English — what each one is, where they overlap and where they genuinely differ.
KlothoLongevity
FOXO4-DRILongevityAt a glance
| Klotho | FOXO4-DRI | |
|---|---|---|
| Category | Longevity | Longevity |
| Typical route | SubQ | SubQ |
| Shelf life once mixed | ~30 days | ~30 days |
| Commonly reported effects | Cognitive preservation Kidney protection Cardiovascular support Youthful mitochondrial function | Senescent cell clearance Tissue rejuvenation Hair regrowth reports |
| Reported considerations | Very rare — data limited | Fatigue during clearance Rare flu-like symptoms |
The differences that actually matter
Both are classed as Longevity peptides, so they get compared constantly and are often researched for overlapping reasons.
Reported mainly for Klotho: cognitive preservation, kidney protection, cardiovascular support.
Reported mainly for FOXO4-DRI: senescent cell clearance, tissue rejuvenation, hair regrowth reports.
What Klotho is
Klotho is a protein existing in both membrane-bound and soluble forms, playing diverse roles in physiological regulation. The membrane-bound form acts as a co-receptor for Fibroblast Growth Factor 23 (FGF23), a hormone critical for phosphate and vitamin D metabolism in the kidneys. Soluble Klotho, which is shed from the cell surface into the circulation, functions as a humoral factor impacting various tissues. This soluble form is understood to modulate multiple signaling pathways, including those involving insulin
What FOXO4-DRI is
FOXO4-DRI is a peptide designed to disrupt the interaction between the Forkhead box protein O4 (FOXO4) and the tumor suppressor protein p53. In senescent cells, FOXO4 forms a complex with p53, which inhibits p53's ability to activate pro-apoptotic pathways. FOXO4-DRI acts by competitively binding to FOXO4, effectively freeing p53 to initiate programmed cell death specifically in these "zombie" cells. This selective mechanism targets the removal of accumulated senescent cells that are implicated in driving various a
How to compare them for yourself
Anecdotes online are noisy because nobody is measuring the same thing. The only comparison that means anything is your own: log each entry with a timestamp, keep the vial ledger honest so you know what you actually got through, pick two or three metrics before you start, and look at the trend after several weeks rather than day to day.
Peptide Wizard does that part for you — Klotho and FOXO4-DRI are both in the built-in reference library with a 3D vial, and your history, vial ledger and cost per entry stay private on your device.
FAQ
What is the difference between Klotho and FOXO4-DRI?
Both are classed as Longevity peptides, so they get compared constantly and are often researched for overlapping reasons.
Can you log Klotho and FOXO4-DRI in the same period?
Plenty of people record more than one peptide at a time. Peptide Wizard keeps a separate vial ledger and entry history for each, so you can see exactly what overlapped and when — it does not recommend combinations or doses.
Which is better, Klotho or FOXO4-DRI?
There isn't a universal answer — reported responses vary a lot between individuals, which is why your own log is more informative than anyone else's anecdote. Track one variable at a time and compare your own metrics over several weeks.
Is this medical advice?
No. This page is educational reference material only. It contains no dosing guidance. Speak to a qualified healthcare professional before making any decisions.
See all peptide comparisons →
Educational reference only. This page contains no dosing guidance and is not medical advice.